---
$id: https://graph.org.ai/products/commodity/51152009
$type: Product
source: UNSPSC
code: "51152009"
title: "Pancuronium"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pancuronium

**UNSPSC Code**: 51152009
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C35H60N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J76UF062FS, chemically known as 5.alpha.-androstan-3.alpha.,17.beta.-diol, 2.beta., 16.beta.-dipipecolinio-, dibromide, diacetate but generally known as pancuronium, which bears US NIH Compound Identifier 4675. European Medicines Agency schedules Pancuronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03618MIG. World Health Organization schedules pancuronium in its Anatomical Therapeutic Chemical (ATC) Classification. PANCURONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, PANCURONIUM remains the US FDA Preferred Term for this commodity. Pancuronium bears US NLM identifiers UMLS ID C0030310 and NCI Concept Code C61876. SMILES: O(C1C2(C(C3C(C4(C(CC3)CC(OC(=O)C)C([N]3(CCCCC3)C)C4)C)CC2)CC1[N]1(CCCCC1)C)C)C(=O)C.

